Table 2

Incidence of CDKN2A deletions by sex, age, white cell count, and cytogenetic subgroup in childhood acute lymphoblastic leukemia (ALL)

SubgroupBCP-ALL cohort
T-ALL cohort
TotalDeletion, n (%)Biallelic deletion, n (% of deleted cases)TotalDeletion, n (%)Biallelic deletion, n (% of deleted cases)
Total 864 180 (21) 78 (43)  266 134 (50) 83 (62) 
Sex 
    Male 473 96 (20) 43 (45)  191 96 (50) 63 (66) 
    Female 391 84 (21) 35 (42)  75 38 (51) 20 (53) 
Age groups 
    < 10 y 679 129 (19)g 53 (41)  141 81 (57)g 47 (58) 
    10+ y 185 51 (28)g 25 (49)  125 53 (42)g 36 (68) 
White cell counta 
    < 50 × 109/L 636 109 (17)h 50 (46)  82 37 (45) 23 (62) 
    > 50 × 109/L 154 55 (36)h 19 (35)  172 88 (51) 55 (63) 
Cytogenetic subgroupsb    Cytogenetic subgroupsb    
    High hyperdiploidyc 279 30 (11)h 14 (47)     TAL1 rearrangementsi 49 21 (43) 12 (57) 
    ETV6-RUNX1 218 33 (15)g 15 (45)     TLX3 rearrangementsj 41 31 (76)h 18 (58) 
    t(1;19)(q23;p13) 25 10 (40)g 2 (20)     LMO2 rearrangementsk 23 9 (39) 6 (67) 
    MLL translocationsd 22 2 (9) 1 (50)     MLL translocationsd 11 2 (18) 1 (50) 
    t(9;22)(q34;q11) 19 11 (58)h 1 (9)g     TLX1 abnormalitiesl 8 (89)g 4 (50) 
    iAMP21e 19 5 (26) 3 (60)     AF10-CALM 4 (44) 1 (25) 
    Normal karyotypef 52 6 (12) 6 (100)h     Normal karyotypef 55 23 (42) 18 (78) 
SubgroupBCP-ALL cohort
T-ALL cohort
TotalDeletion, n (%)Biallelic deletion, n (% of deleted cases)TotalDeletion, n (%)Biallelic deletion, n (% of deleted cases)
Total 864 180 (21) 78 (43)  266 134 (50) 83 (62) 
Sex 
    Male 473 96 (20) 43 (45)  191 96 (50) 63 (66) 
    Female 391 84 (21) 35 (42)  75 38 (51) 20 (53) 
Age groups 
    < 10 y 679 129 (19)g 53 (41)  141 81 (57)g 47 (58) 
    10+ y 185 51 (28)g 25 (49)  125 53 (42)g 36 (68) 
White cell counta 
    < 50 × 109/L 636 109 (17)h 50 (46)  82 37 (45) 23 (62) 
    > 50 × 109/L 154 55 (36)h 19 (35)  172 88 (51) 55 (63) 
Cytogenetic subgroupsb    Cytogenetic subgroupsb    
    High hyperdiploidyc 279 30 (11)h 14 (47)     TAL1 rearrangementsi 49 21 (43) 12 (57) 
    ETV6-RUNX1 218 33 (15)g 15 (45)     TLX3 rearrangementsj 41 31 (76)h 18 (58) 
    t(1;19)(q23;p13) 25 10 (40)g 2 (20)     LMO2 rearrangementsk 23 9 (39) 6 (67) 
    MLL translocationsd 22 2 (9) 1 (50)     MLL translocationsd 11 2 (18) 1 (50) 
    t(9;22)(q34;q11) 19 11 (58)h 1 (9)g     TLX1 abnormalitiesl 8 (89)g 4 (50) 
    iAMP21e 19 5 (26) 3 (60)     AF10-CALM 4 (44) 1 (25) 
    Normal karyotypef 52 6 (12) 6 (100)h     Normal karyotypef 55 23 (42) 18 (78) 
a

Data are missing for 86 patients.

b

Patients with each specific abnormality were compared with either all other patients with successful cytogenetics or those who tested negative for that particular abnormality by FISH, as appropriate.

c

Karyotypes with 51 to 65 chromosomes.

d

Patients positive by FISH or with an established translocation by G-banded analysis.

e

Intrachromosomal amplification of chromosome 21.

f

A normal karyotype was defined as the presence of 20 or more normal metaphases and the absence of any cytogenetically visible abnormality or any abnormality detected by FISH.

g

P < .05.

h

P < .01.

i

Involvement of TAL1 was confirmed by FISH in all cases. Group comprised SIL-TAL1 (n = 43), t(1;14)(p32;q11)/TAL1-TRA@/TRD@ (n = 5), and t(1;14)(p32;q32)/TAL1-IGH@ (n = 1).

j

Involvement of TLX3 (HOX11L2) was confirmed by FISH in all cases. In 33 cases, BCL11B was also confirmed to be involved, ie, t(5;14)(q35;q32).

k

Involvement of LMO2 was confirmed by FISH in all cases and the partner gene was identified in 20 cases: t(11;14)(p13;q11)/LMO2-TRA@/TRD@ (n = 15), t(7;11)(q34;p13)/LMO2-TRB@ (n = 3), t(7;11)(p15;p13)/LMO2-TRG@ (n = 1), and t(11;14)(p13;q32)/LMO2-BCL11B (n = 1).

l

Involvement of TLX1 (HOX11) was confirmed by FISH in all cases and the partner gene was identified in 7 cases: t(10;14)(q24;q11)/TLX1-TRA@/TRD@ (n = 4) and t(7;10)(q36;q24)/TLX1-TRB@ (n = 3).

or Create an Account

Close Modal
Close Modal